Barclays Trims Keurig Dr Pepper (NASDAQ:KDP) Target Price to $39.00

by · The Markets Daily

Keurig Dr Pepper (NASDAQ:KDPGet Free Report) had its price objective lowered by equities research analysts at Barclays from $41.00 to $39.00 in a report released on Monday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target indicates a potential upside of 12.81% from the stock’s current price.

KDP has been the topic of several other reports. Evercore ISI upgraded Keurig Dr Pepper to a “hold” rating in a research report on Thursday, September 5th. JPMorgan Chase & Co. lowered their price target on shares of Keurig Dr Pepper from $41.00 to $40.00 and set an “overweight” rating for the company in a report on Friday. Wells Fargo & Company cut their price target on shares of Keurig Dr Pepper from $43.00 to $42.00 and set an “overweight” rating on the stock in a report on Friday. Jefferies Financial Group dropped their target price on shares of Keurig Dr Pepper from $42.00 to $41.00 and set a “buy” rating for the company in a report on Friday. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Keurig Dr Pepper from $36.00 to $37.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $38.36.

Get Our Latest Stock Report on KDP

Keurig Dr Pepper Price Performance

Shares of NASDAQ KDP traded down $0.01 during trading hours on Monday, reaching $34.57. 904,015 shares of the stock traded hands, compared to its average volume of 8,656,532. The company’s 50-day simple moving average is $36.73 and its two-hundred day simple moving average is $34.67. The company has a market capitalization of $46.86 billion, a P/E ratio of 22.30, a price-to-earnings-growth ratio of 2.73 and a beta of 0.62. Keurig Dr Pepper has a 52-week low of $28.61 and a 52-week high of $38.28. The company has a quick ratio of 0.34, a current ratio of 0.51 and a debt-to-equity ratio of 0.50.

Keurig Dr Pepper (NASDAQ:KDPGet Free Report) last announced its quarterly earnings data on Thursday, October 24th. The company reported $0.51 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.51. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Keurig Dr Pepper had a net margin of 14.47% and a return on equity of 10.32%. The firm’s revenue was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.48 EPS. Equities research analysts forecast that Keurig Dr Pepper will post 1.92 EPS for the current year.

Institutional Trading of Keurig Dr Pepper

Hedge funds and other institutional investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD increased its stake in Keurig Dr Pepper by 107.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 23,654,577 shares of the company’s stock worth $725,487,000 after buying an additional 12,259,471 shares in the last quarter. Vanguard Group Inc. grew its holdings in Keurig Dr Pepper by 9.4% during the 1st quarter. Vanguard Group Inc. now owns 90,840,391 shares of the company’s stock valued at $2,786,075,000 after buying an additional 7,825,418 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Keurig Dr Pepper by 41.8% in the second quarter. Dimensional Fund Advisors LP now owns 6,373,362 shares of the company’s stock worth $212,901,000 after buying an additional 1,878,597 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in shares of Keurig Dr Pepper during the second quarter worth $37,643,000. Finally, Armistice Capital LLC grew its stake in Keurig Dr Pepper by 186.3% during the second quarter. Armistice Capital LLC now owns 1,486,063 shares of the company’s stock valued at $49,635,000 after acquiring an additional 966,924 shares in the last quarter. 85.23% of the stock is owned by hedge funds and other institutional investors.

Keurig Dr Pepper Company Profile

(Get Free Report)

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

Further Reading